Skip to main content
. 2022 Jul 6;7(1):e000925. doi: 10.1136/tsaco-2022-000925

Table 1.

Demographic and comorbidity comparison between the LBD group and the LBD+SBO group

Demographic/comorbidity LBD (n=170) LBD+SBO (n=34) P value
Mean age (years) (SD) 65.0 (15.5) 67.1 (17.0) 0.5
Race, n (%) Black 31 (18) 7 (21) 0.94
White 133 (78) 26 (76)
Other 6 (4) 1 (3)
Sex, n (%) Male 79 (46) 17 (50) 0.71
Female 91 (54) 17 (50)
Prior abdominal surgery, n (%) No 149 (88) 31 (91) 0.56
Yes 21 (12) 3 (9)
Diabetes, n (%) No 154 (91) 31 (91) 0.91
Yes 16 (9) 3 (9)
Hinchey class, n (%) 1 or 2 152 (90) 28 (82) 0.2
3 or 4 14 (10) 6 (18)
Immunosuppression, n (%) No 156 (92) 33 (97) 0.28
Yes 14 (8) 1 (3)
Congestive heart failure, n (%) No 156 (92) 33 (97) 0.28
Yes 14 (8) 1 (3)
Coronary artery disease, n (%) No 140 (82) 30 (88) 0.4
Yes 30 (18) 4 (12)
Chronic lung disease, n (%) No 145 (85) 31 (91) 0.36
Yes 25 (15) 3 (9)
Obesity, n (%) No 134 (79) 30 (88) 0.21
Yes 36 (21) 4 (12)
Renal failure, n (%) No 155 (91) 32 (94) 0.57
Yes 15 (9) 2 (6)
Hypertension, n (%) No 160 (94) 31 (91) 0.52
Yes 10 (6) 3 (9)
Tachycardia, n (%) No 166 (98) 33 (97) 0.84
Yes 4 (2) 1 (3)

LBD, large bowel diverticulitis; SBO, small bowel obstruction.